Trademark Overview
On Tuesday, September 18, 2018, a trademark application was filed for INNOCRIN with the United States Patent and Trademark Office. The USPTO has given the INNOCRIN trademark a serial number of 88121195. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, August 23, 2019. This trademark is owned by Innocrin Pharmaceuticals, Inc.. The INNOCRIN trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Pharmaceutical preparations and treatment regimens for the treatment of androgen receptor targeted tumors, including breast and prostate cancer; pharmaceutical, biopharmaceutical, therapeutic, diagnostic, and biomedical agents for medical use; diagnostic, therapeutic and biomedical regimens for medical use; scientific research, pharmaceutical research, medical research, technical consultation and product development for others in the field of biotechnology and development of pharmaceuticals, therapeutic agents; pharmaceutical compositions for treatment of disease